SE8001339L - ANTIHYPERCOLESTEREMIC MEDICINE, MONACOLINE K AND PREPARATION OF THEREOF - Google Patents

ANTIHYPERCOLESTEREMIC MEDICINE, MONACOLINE K AND PREPARATION OF THEREOF

Info

Publication number
SE8001339L
SE8001339L SE8001339A SE8001339A SE8001339L SE 8001339 L SE8001339 L SE 8001339L SE 8001339 A SE8001339 A SE 8001339A SE 8001339 A SE8001339 A SE 8001339A SE 8001339 L SE8001339 L SE 8001339L
Authority
SE
Sweden
Prior art keywords
antihypercolesteremic
monacoline
medicine
preparation
monascus
Prior art date
Application number
SE8001339A
Other languages
Swedish (sv)
Other versions
SE453301B (en
Inventor
A Endo
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of SE8001339L publication Critical patent/SE8001339L/en
Publication of SE453301B publication Critical patent/SE453301B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A new compound which we refer to as Monacolin K, has the molecular formula C24H36O5 and has been found to have valuable antihypercholesteraemic activity. It can be produced by cultivating suitable micro-organisms from the genus Monascus, especially Monascus ruber strain 1005 (FERM 4822).
SE8001339A 1979-02-20 1980-02-20 ANTIHYPERCOLESTEROLEMIC MEDICINE, MONACOLINE K, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME SE453301B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP54017856A JPS5925599B2 (en) 1979-02-20 1979-02-20 New physiologically active substance monacolin K and its production method

Publications (2)

Publication Number Publication Date
SE8001339L true SE8001339L (en) 1980-08-21
SE453301B SE453301B (en) 1988-01-25

Family

ID=11955290

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8001339A SE453301B (en) 1979-02-20 1980-02-20 ANTIHYPERCOLESTEROLEMIC MEDICINE, MONACOLINE K, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME

Country Status (27)

Country Link
JP (1) JPS5925599B2 (en)
KR (1) KR830002801B1 (en)
AT (1) AT373915B (en)
AU (1) AU532626B2 (en)
BE (1) BE881825A (en)
CA (1) CA1129794A (en)
CH (1) CH645890A5 (en)
DD (1) DD154494A5 (en)
DE (2) DE3006216C2 (en)
DK (2) DK149095C (en)
ES (1) ES488796A0 (en)
FI (1) FI66427C (en)
FR (1) FR2449685B1 (en)
GB (1) GB2046737B (en)
HU (1) HU182069B (en)
IE (1) IE49743B1 (en)
IT (1) IT1175260B (en)
MX (1) MX6314E (en)
NL (1) NL191540C (en)
NO (1) NO153974C (en)
NZ (1) NZ192919A (en)
PH (1) PH15145A (en)
PL (1) PL124304B1 (en)
SE (1) SE453301B (en)
SG (1) SG6784G (en)
SU (2) SU1158048A3 (en)
ZA (1) ZA80962B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
JPS5621594A (en) * 1979-07-27 1981-02-28 Sankyo Co Ltd Mb-530b carboxylic acid metal salt and its preparation
PT72394B (en) * 1980-02-04 1982-09-06 Merck & Co Inc Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
JPH0692381B2 (en) * 1980-03-31 1994-11-16 三共株式会社 MB-530A derivative
JPS56142236A (en) 1980-04-08 1981-11-06 Sankyo Co Ltd Ml-236a and mb-530a derivative
DK149080C (en) * 1980-06-06 1986-07-28 Sankyo Co METHOD FOR PREPARING ML-236B CARBOXYLIC ACID DERIVATIVES
JPS5835144A (en) * 1981-08-27 1983-03-01 Sankyo Co Ltd Mb-530b derivative and its preparation
US4782084A (en) * 1987-06-29 1988-11-01 Merck & Co., Inc. HMG-COA reductase inhibitors
US4997848A (en) * 1987-10-27 1991-03-05 Sankyo Company, Limited Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition
CA2062023A1 (en) * 1992-02-10 1993-08-11 Jagroop S. Dahiya Novel fungal strains and use thereof in antibiotic production
WO1993017991A1 (en) * 1992-03-04 1993-09-16 Fujisawa Pharmaceutical Co., Ltd. TETRALIN DERIVATIVES AS HMG-CoA REDUCTASE INHIBITORS
NZ247617A (en) 1992-05-15 1995-07-26 Sankyo Co Octahydronaphthalene oxime derivatives and pharmaceutical compositions
US6812007B1 (en) * 1992-11-04 2004-11-02 Keri Vilmos Process for the isolation and purification of mevinolin
HU210867B (en) * 1992-11-04 1995-10-30 Biogal Gyogyszergyar Method for extraction and purification of mevinolin from culture medium
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
US5409820A (en) * 1993-08-06 1995-04-25 Apotex, Inc. Process for the production of lovastatin using Coniothyrium fuckelii
US6046022A (en) 1996-09-30 2000-04-04 Peking University Methods and compositions employing red rice fermentation products
US7238348B2 (en) 1996-09-30 2007-07-03 Beijing Peking University Wbl Corporation Ltd. Method of treatment of osteoporosis with compositions of red rice fermentation products
IL132822A0 (en) 1998-03-20 2001-03-19 Biogal Gyogyszergyar Metabolic controlled fermentation procedure for the manufacture of lovastatin hydroxy acid
PL357946A1 (en) 2000-02-24 2004-08-09 Biogal Gyogyszergyar Rt Method of purifying a fermentation broth
DE01913139T1 (en) 2000-03-03 2005-03-31 Plus Chemical S.A. A METHOD OF CLEANING LOVASTATIN AND SIMVASTATIN WITH A REDUCED CONTENT OF DIMERIC CONTAMINANTS
KR20010095780A (en) * 2000-04-12 2001-11-07 나가오카 마사시 Embryo monascus
IN192861B (en) 2000-06-30 2004-05-22 Ranbaxy Lab Ltd
EP1358343A2 (en) * 2001-02-09 2003-11-05 Unilever N.V. Process for the preparation of one or more statins by fermentation
KR100379075B1 (en) 2002-03-07 2003-04-08 Jinis Biopharmaceuticals Co Method for producing low cholesterol animal food product and food product therefrom
KR20020093147A (en) * 2002-05-30 2002-12-13 지니스생명공학 주식회사 Preventive and Dietary Supplement for adult chronic disease
KR100710500B1 (en) 2005-05-18 2007-04-24 고려대학교 산학협력단 Method for producing Monacolin K using Monascus sp
WO2010069593A1 (en) 2008-12-19 2010-06-24 Krka, D. D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
EP2327682A1 (en) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
RO128803A0 (en) 2012-10-12 2013-09-30 Ion Gigel Fulga Composition for the treatment or prevention of dyslipidemias
CN110331151A (en) * 2019-04-11 2019-10-15 北京工商大学 The construction method of purple Monascus mokH gene overexpression bacterial strain
CN111297938A (en) * 2020-03-11 2020-06-19 北京康立生医药技术开发有限公司 Method for detecting lovastatin in composition for assisting in reducing blood fat

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (en) 1974-06-07 1981-03-18
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
GR69216B (en) * 1979-06-15 1982-05-07 Merck & Co Inc

Also Published As

Publication number Publication date
MX6314E (en) 1985-04-01
PH15145A (en) 1982-08-24
NL8001041A (en) 1980-08-22
ES8103171A1 (en) 1981-02-16
IT8067262A0 (en) 1980-02-20
DE3006216A1 (en) 1980-09-04
DE3006216C2 (en) 1985-10-31
ZA80962B (en) 1981-03-25
CH645890A5 (en) 1984-10-31
BE881825A (en) 1980-08-20
KR830002030A (en) 1983-05-21
IE800321L (en) 1980-08-20
GB2046737A (en) 1980-11-19
NL191540B (en) 1995-05-01
DE3051175C2 (en) 1989-12-21
SE453301B (en) 1988-01-25
DK73080A (en) 1980-08-21
SG6784G (en) 1985-02-08
HU182069B (en) 1983-12-28
PL222120A1 (en) 1980-10-20
AU5567380A (en) 1980-08-28
AU532626B2 (en) 1983-10-06
SU969702A1 (en) 1982-10-30
NL191540C (en) 1995-09-04
JPS55111790A (en) 1980-08-28
ATA92980A (en) 1983-07-15
IT1175260B (en) 1987-07-01
FI66427C (en) 1984-10-10
FR2449685A1 (en) 1980-09-19
DK21889A (en) 1989-01-18
NO153974C (en) 1986-06-25
IE49743B1 (en) 1985-12-11
DK149095C (en) 1986-06-16
NO153974B (en) 1986-03-17
DK149095B (en) 1986-01-20
CA1129794A (en) 1982-08-17
NZ192919A (en) 1984-07-06
KR830002801B1 (en) 1983-12-16
FI800506A (en) 1980-08-21
JPS5925599B2 (en) 1984-06-19
AT373915B (en) 1984-03-12
FR2449685B1 (en) 1985-06-28
DD154494A5 (en) 1982-03-24
NO800451L (en) 1980-08-21
PL124304B1 (en) 1983-01-31
ES488796A0 (en) 1981-02-16
FI66427B (en) 1984-06-29
SU1158048A3 (en) 1985-05-23
GB2046737B (en) 1983-01-12
DK21889D0 (en) 1989-01-18

Similar Documents

Publication Publication Date Title
SE8001339L (en) ANTIHYPERCOLESTEREMIC MEDICINE, MONACOLINE K AND PREPARATION OF THEREOF
Tamura et al. Ascochlorin, a new antibiotic, found by paper-disc agar-diffusion method. I isolation, biological and chemical properties of ascochlorin (studies on antiviral and antitumor antibiotics. I)
NO176766C (en) Process for the preparation of a compound having anthelmintic activity
FI931680A (en) FOERBAETTRAT FOERFARANDE FOER SYNTETISERING AV (4R-CIS) -1,1-DIMETHYLTHYL-6-CYANOMETHYL-2,2-DIMETHYL-1,3-DIOXAN-4-ACETATE
SE8701483L (en) "MONOCOLIN K" PREPARATION
DE69017946T2 (en) Cell growth-inhibiting macrocyclic lactones called combretastatin D-2.
BR8600329A (en) 1,3-THIAZOL COMPOUND, PROCESS FOR ITS PREPARATION, INSECTICIDE COMPOSITION AND PROCESS TO COMBAT INSECTS
JPS5592387A (en) Antibiotic substance tm-531
JPS56128774A (en) New physiologically active substance ebelactone and its preparation
SE8100134L (en) THERPENOIDS, PROCEDURES FOR THE PREPARATION OF THESE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
KR890014457A (en) Novel azoxy compound and preparation method thereof
JPS57139080A (en) 14,15-epoxy derivative of antibiotic substance b-41 and its preparation
SE7910626L (en) NEW ANTIBIOTIC BN-183B SUBSTANCE AND PROCEDURES FOR PRODUCING THEREOF
FI810710L (en) OLIGORIBOCIDDERIVAT AV HOMOCITRONSYRA FOERFARANDE FOER FRAMSTAELLNING AV DESSA OCH ANVAENDNINGEN AV DESSA FOER FOERHINDRANDE AV KARIES
ES480904A1 (en) Antibiotic substance
GB2093347B (en) Immunostimulant material tf-2 from fusobacterium sp
SE7711542L (en) PROCEDURE FOR THE PREPARATION OF A NEW ANTIBIOTIC C-15003 AND HYDROLYSIS DERIVATIVES
SE8005921L (en) NEW ASSOCIATIONS WITH CARCINOSTATIC AND IMMUNOSTIMULATING ACTIVITY AND PROCEDURE FOR PREPARING THEREOF
JPS5692786A (en) Cultivation of microorganism
JPS5651435A (en) Novel substance dc-44-a and dc-44-b, and their preparation
KR920002497A (en) Sterol compound
JPS54128575A (en) Novel pentalenonelactone compound and drugs comprising it as active constituent
JPS5492680A (en) Novel microorganism
JPS574975A (en) Phenazine derivative and its preparation
JPS5484095A (en) Preparation of novel ribostamycin

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8001339-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8001339-4

Format of ref document f/p: F